|
phylogeny |
15 |
|
molecular sequence data |
13 |
|
china - epidemiology |
12 |
|
influenza |
12 |
|
animals |
11 |
|
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
10 |
|
swine - virology |
10 |
|
animal |
9 |
|
astroviridae infections - epidemiology - veterinary - virology |
9 |
|
chiroptera - classification - virology |
9 |
|
evolution, molecular |
9 |
|
flavivirus |
9 |
|
genetic variation |
9 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
|
interferon |
9 |
|
mamastrovirus - classification - genetics - isolation & purification |
9 |
|
model |
9 |
|
molecular sequence numbers |
9 |
|
mouse |
9 |
|
orchitis |
9 |
|
prevalence |
9 |
|
sequence analysis, dna |
9 |
|
species specificity |
9 |
|
steroid |
9 |
|
swine - blood - virology |
9 |
|
swine diseases - blood - epidemiology - transmission - virology |
9 |
|
testis |
9 |
|
treatment |
9 |
|
zika |
9 |
|
disease outbreaks |
8 |
|
genotype |
8 |
|
humans |
8 |
|
influenza, human - epidemiology - virology |
8 |
|
influenza a virus - classification - genetics |
7 |
|
influenza in birds - transmission - virology |
7 |
|
influenza, human - transmission - virology |
7 |
|
abattoirs |
6 |
|
fractional factorial design |
6 |
|
genes, viral |
6 |
|
h7n9 |
6 |
|
hemagglutinin glycoproteins, influenza virus - genetics |
6 |
|
hong kong |
6 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h1n2 subtype - classification - genetics - isolation & purification |
6 |
|
influenza polymerase |
6 |
|
influenza virus |
6 |
|
neuraminidase - genetics |
6 |
|
population surveillance |
6 |
|
reassortant viruses - classification - genetics - isolation & purification |
6 |
|
regional index: china |
6 |
|
swine diseases - epidemiology - transmission - virology |
6 |
|
antibodies, neutralizing - blood - immunology |
5 |
|
antibodies, viral - blood - immunology |
5 |
|
immunity |
5 |
|
influenza a virus - classification - genetics - immunology - isolation and purification |
5 |
|
influenza a virus - classification - genetics - isolation and purification - pathogenicity |
5 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification |
5 |
|
influenza a virus, h1n1 subtype - immunology |
5 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation and purification |
5 |
|
influenza, human - epidemiology - immunology |
5 |
|
orthomyxoviridae infections - epidemiology - immunology |
5 |
|
orthomyxoviridae infections - epidemiology - veterinary - virology |
5 |
|
orthomyxoviridae infections - transmission - virology |
5 |
|
reassortant viruses - classification - genetics - isolation and purification |
5 |
|
reassortant viruses - classification - genetics - isolation and purification - pathogenicity |
5 |
|
rna, viral - genetics |
5 |
|
sars-cov-2 |
5 |
|
swine diseases - epidemiology - virology |
5 |
|
amino acid substitution |
4 |
|
animals, domestic - virology |
4 |
|
animals, wild - virology |
4 |
|
bioconductor |
4 |
|
biomarker |
4 |
|
birds - virology |
4 |
|
cell line |
4 |
|
china |
4 |
|
coinfection - virology |
4 |
|
communicable diseases, emerging - epidemiology - history - virology |
4 |
|
data integration |
4 |
|
disease burden |
4 |
|
dogs |
4 |
|
drug resistance, viral |
4 |
|
ducks - virology |
4 |
|
female |
4 |
|
gene pool |
4 |
|
history, 20th century |
4 |
|
history, 21st century |
4 |
|
human |
4 |
|
influenza a virus - genetics - isolation and purification |
4 |
|
influenza a virus - isolation and purification |
4 |
|
influenza a virus, h1n1 subtype - genetics |
4 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
4 |
|
influenza a virus, h1n1 subtype - pathogenicity |
4 |
|
influenza a virus, h1n2 subtype - pathogenicity |
4 |
|
influenza a virus, h3n2 subtype - genetics |
4 |
|
influenza a virus, h7n9 subtype - drug effects - genetics - isolation and purification |
4 |
|
influenza in birds - epidemiology - history - virology |
4 |
|
influenza in birds - epidemiology - transmission |
4 |
|
influenza, human - epidemiology - history - virology |
4 |
|
influenza, human - epidemiology - immunology - transmission |
4 |
|
influenza, human - virology |
4 |
|
lysine - genetics |
4 |
|
metagenomics |
4 |
|
mice |
4 |
|
mice, inbred balb c |
4 |
|
migratory ducks |
4 |
|
mutation, missense |
4 |
|
nonhuman |
4 |
|
orthomyxoviridae infections - transmission |
4 |
|
orthomyxoviridae infections - veterinary - virology |
4 |
|
pandemic influenza |
4 |
|
pandemics |
4 |
|
pandemics - history |
4 |
|
pandemics control |
4 |
|
pathogenicity |
4 |
|
pb2 627 residue |
4 |
|
pholidota (animal) |
4 |
|
reassortant viruses - genetics - isolation and purification |
4 |
|
recombination, genetic |
4 |
|
respiratory infections |
4 |
|
rsv |
4 |
|
sentinel ducks |
4 |
|
sex difference |
4 |
|
survival |
4 |
|
swine diseases - virology |
4 |
|
temperature-sensitivity |
4 |
|
viral proteins - genetics |
4 |
|
virulence |
4 |
|
virulence - genetics |
4 |
|
virus interactions |
4 |
|
virus replication |
4 |
|
zoonoses |
4 |
|
annotation |
3 |
|
antigens, viral - analysis |
3 |
|
apoptosis |
3 |
|
avian influenza |
3 |
|
caliciviridae infections - virology |
3 |
|
capsid proteins - genetics |
3 |
|
chicken |
3 |
|
clade 2.3.4.4 |
3 |
|
coinfection |
3 |
|
communicable diseases, emerging - virology |
3 |
|
ducks |
3 |
|
efficacy of controls |
3 |
|
environmental transmission |
3 |
|
eurasian gene pool |
3 |
|
evolution |
3 |
|
ferret |
3 |
|
gastroenteritis - virology |
3 |
|
genomic analysis |
3 |
|
ggtree |
3 |
|
h3n8 |
3 |
|
h5n1 |
3 |
|
h5n8 |
3 |
|
host specificity |
3 |
|
immune response |
3 |
|
immunodynamics |
3 |
|
incidence |
3 |
|
infectivity |
3 |
|
influenza antibody levels (流感抗體水平) |
3 |
|
influenza in birds - epidemiology - virology |
3 |
|
live bird market |
3 |
|
live-bird markets |
3 |
|
migratory bird |
3 |
|
norovirus - genetics |
3 |
|
pandemic influenza a virus |
3 |
|
pathogenesis |
3 |
|
phylodynamics |
3 |
|
pregnancy |
3 |
|
r package |
3 |
|
reassortment |
3 |
|
respiratory disease |
3 |
|
risk |
3 |
|
rna virus |
3 |
|
rural and urban households (社區人群) |
3 |
|
serology |
3 |
|
social contact (人際接觸) |
3 |
|
transmissibility |
3 |
|
virosphere |
3 |
|
visualization |
3 |
|
wholesale markets |
3 |
|
zoonosis |
3 |
|
antibody response |
2 |
|
ards |
2 |
|
avian |
2 |
|
biomimetic nanocarrier |
2 |
|
biosafety |
2 |
|
butyrate |
2 |
|
cell membrane vesicles |
2 |
|
clinical severity |
2 |
|
co-infection |
2 |
|
critical community size |
2 |
|
cross-protection |
2 |
|
cross-variant neutralization |
2 |
|
elderly |
2 |
|
endogenous type i interferon |
2 |
|
follow-up |
2 |
|
genome structure |
2 |
|
golden hamster |
2 |
|
h7n9 virus |
2 |
|
hemagglutination inhibition test |
2 |
|
hepatocellular carcinoma |
2 |
|
highly pathogenic coronavirus |
2 |
|
homologous and heterologous rechallenge |
2 |
|
human case |
2 |
|
human lung |
2 |
|
humanized mouse model |
2 |
|
imbalanced innate immune responses |
2 |
|
immunogenicity |
2 |
|
immunology |
2 |
|
immunopathogenesis |
2 |
|
infection |
2 |
|
influenza a(h7n9) |
2 |
|
influenza a/h7n9 |
2 |
|
influenza h7n9 |
2 |
|
influenza h7n9 virus |
2 |
|
kw048 - embryonic stem cell |
2 |
|
kw064 - functional motifs |
2 |
|
kw092 - inheritance patterns |
2 |
|
kw151 - regulation of transcription |
2 |
|
kw164 - systems biology |
2 |
|
microneutralization test |
2 |
|
neutralization test |
2 |
|
newcastle disease virus |
2 |
|
non-human primates |
2 |
|
omicron |
2 |
|
oncolytic effectiveness |
2 |
|
oxidative stress |
2 |
|
pandemic |
2 |
|
prime-boost |
2 |
|
r0 |
2 |
|
severe acute respiratory syndrome |
2 |
|
severe disease |
2 |
|
stochastic model |
2 |
|
type i ifn |
2 |
|
type i interferon |
2 |
|
vaccine and drug discovery |
2 |
|
vaccines |
2 |
|
variation and function |
2 |
|
xenograft |
2 |
|
adenosine |
1 |
|
ampk/mtor/ulk1 |
1 |
|
anti-fungi |
1 |
|
autophagy |
1 |
|
canine influenza virus |
1 |
|
cnaphalocrocis medinalis |
1 |
|
disease resistance |
1 |
|
endoplasmic reticulum stress |
1 |
|
fungi - genetics |
1 |
|
galanthus - genetics |
1 |
|
gene expression |
1 |
|
global proteomic analysis |
1 |
|
gna gene |
1 |
|
h3n2 |
1 |
|
hemiptera |
1 |
|
immunity, innate - genetics |
1 |
|
inheritance |
1 |
|
insect resistance |
1 |
|
insects |
1 |
|
mannose-binding lectins - genetics - metabolism |
1 |
|
multi-gene transformation |
1 |
|
neutralizing antibody |
1 |
|
nilapavata lugens |
1 |
|
oryza sativa - genetics - microbiology |
1 |
|
oryza sativa - genetics - parasitology |
1 |
|
plant diseases - genetics - microbiology |
1 |
|
plant lectins - genetics - metabolism |
1 |
|
plants, genetically modified |
1 |
|
plants, genetically modified - parasitology |
1 |
|
pseudovirus |
1 |
|
rice blast |
1 |
|
rice false smut |
1 |
|
rice kernel smut |
1 |
|
sbti gene |
1 |
|
soybeans - genetics |
1 |
|
spike protein |
1 |
|
super hybrid rice |
1 |
|
tandem mass spectrometry |
1 |
|
transgenes |
1 |
|
transgenic rice |
1 |
|
trypsin inhibitors - genetics - metabolism |
1 |
|
vaccination |
1 |
|
中枢神经系统感染 |
1 |
|
甲型流感病毒 |
1 |
|
病毒血症 |
1 |
